Skip to main content

Table 3 Cox analysis of risk factors associated with recurrence

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Characteristics

Univariable

Multivariable

HR

95% CI

p value

HR

95%CI

p value

Age (years)

1.105

0.965–1.241

0.314

 

BMI (kg/m2)

1.165

0.823–1.284

0.287

SBP (mmHg)

1.112

0.963–1.323

0.432

DBP (mmHg)

1.223

0.932–1.444

0.642

Triglycerides (mmol/L)

1.013

0.862–1.152

0.426

HDL (mmol/L)

1.104

1.013–1.324

0.023*

1.312

0.913–1.632

0.452

LDL (mmol/L)

1.342

0.982–1.552

0.313

 

Fasting glucose (mmol/L)

1.122

0.951–1.302

0.524

CEA (ng/ml)

1.123

1.032–1.452

0.014*

1.127

0.972–1.516

0.292

Differentiation

0.882

0.823–0.965

0.009*

0.904

0.832–1.176

0.128

Location

1.302

0.921–1.542

0.392

 

 Ascending, transverse, and descending

1.000

 Sigmoid

1.242

0.927–1.423

0.542

 Rectum

1.132

0.912–1.402

0.356

Stage

1.322

1.095–1.932

0.011*

1.522

1.312–1.923

0.008*

 I

1.000

1.000

 II

1.092

0.902–1.123

0.223

1.223

0.922–1.433

0.321

 III

2.123

1.232–2.873

0.001*

1.923

1.321–2.923

0.001*

MetS

1.722

1.224–2.722

0.020*

1.821

1.164–3.121

0.010*

NAFLD

1.542

0.935–2.226

0.109

 

 Non

1.000

 Mild

1.097

0.913–1.198

0.312

 Moderate

1.431

0.921–2.216

0.197

 Severe

1.582

0.945–2.368

0.210

  1. NAFLD, non-alcoholic fatty livers disease, MetS metabolic syndrome, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. *represent the p value ≤ 0.05